Randomized Controlled Trial of Strain-Specific Probiotic Formulation (Renadyl) in Dialysis Patients

Background. Primary goal of this randomized, double-blind, placebo-controlled crossover study of Renadyl in end-stage renal disease patients was to assess the safety and efficacy of Renadyl measured through improvement in quality of life or reduction in levels of known uremic toxins. Secondary goal...

Descripción completa

Detalles Bibliográficos
Autores principales: Natarajan, Ranganathan, Pechenyak, Bohdan, Vyas, Usha, Ranganathan, Pari, Weinberg, Alan, Liang, Peter, Mallappallil, Mary C., Norin, Allen J., Friedman, Eli A., Saggi, Subodh J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4132402/
https://www.ncbi.nlm.nih.gov/pubmed/25147806
http://dx.doi.org/10.1155/2014/568571

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4132402/
https://www.ncbi.nlm.nih.gov/pubmed/25147806
http://dx.doi.org/10.1155/2014/568571

Ejemplares similares